LUGPA 2025 Global Prostate Cancer Congress
The LUGPA 2025 Global Prostate Cancer Congress provides a comprehensive overview of best practices in the prevention, detecti [...]
Predicting Cancer Treatment Response
One of the greatest fantasies in medicine is to one day be able to offer any patient a therapy perfectly adapted to their pro [...]
Optimizing Kubernetes Log Aggregation: Tackling Fluent Bit Buffering and...
At Artera, we rely on Kubernetes (EKS) clusters to run applications, with Fluent Bit handling log forwarding to DataDog for m [...]
Are Open Source Pathology Foundation Models ready for the...
Imagine that a pathologist reads a slide and diagnoses a patient’s cancer on a Monday. They return a few weeks later, read th [...]
How AI personalizes cancer therapy
From images of patients' digitized pathology, AI gets a view of cells of the tumor for recommended therapy and long- term pro [...]
AI significantly improves risk classification for prostate cancer metastasis
An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach [...]
Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond...
In this latest episode of Exploring Artificial Intelligence in Oncology, Fellows Forum member Dr. Waqas Haque sits down with [...]
Artera’s Multimodal Artificial Intelligence Named Among TIME’s 2024 Best...
Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced th [...]